Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas

Eye

Volumn 18, Issue 6, 2004, Pages 619-623

  Richtig, Erika ^a   Langmann, G ^a   Mullner K ^a   Richtig, G ^b   Smolle, J ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b Department of Air Quality Control   (Austria)

Author keywords

Choroidal melanoma; Prognostic parameters; Rotation ellipsoid; Tumour diameter; Tumour height; Tumour volume

Indexed keywords

COBALT 60; RUTHENIUM 106;

A SCAN; ADULT; AGED; ARTICLE; B SCAN; BRACHYTHERAPY; CALCULATION; CANCER SURVIVAL; CHOROID MELANOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GAMMA KNIFE RADIOSURGERY; HEIGHT; HUMAN; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; ONCOLOGICAL PARAMETERS; PROGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 3242679840     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700720     Document Type: Article

References (24)

1. McLean IW, Foster WD, Zimmermann LE. Uveal melanoma: localization, size, cell type and enucleation as risk factors in metastasis. Hum Pathol 1982; 13: 123-132.
2. Mooy CM, De Jong PTVM. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 1996; 41(3): 215-228.
3. Jäckel A, Bock M, Deichmann M, Waldmann V, Näher H. Therapie des metastasierten malignen Uveamelanoms. Hautarzt 2001; 52: 98-103.
4. Wöll E, Bedikian A, Legha SS. Uveal melanoma: natural history and treatment options for metastatic disease. Melanoma Res 1999; 9: 575-581.
5. Char DH, Castro JR, Kroll SM, Irvine AR, Quivey JM, Stone RD. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990; 108: 209-214.
6. Char DH, Kroll SM, Miller T, Castro J, Quivey J. Irradiated uveal melanomas: cytopathologic correlation with prognosis. Am J Ophthalmol 1996; 122: 509-513.
7. Char DH, Kroll S, Phillips TL. Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol 1997; 115: 1014-1018.
8. Castro JR, Char DH, Petti PL, Daftari IK, Quivey JM, Singh RP et al. 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Rad Oncol Biol. Phys 1997; 39(5): 989-996.
9. Augsburger JJ, Gamel JW. Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer 1990; 66: 1596-1600.
10. Singh AD, Shields CL, Shields JA. Prognostic factors in uveal melanoma. Melanoma Res 2001; 11: 255-263.
11. Foss AJE, Alexander RA, Jeffries LW, Hungerford JL, Harris AL, Lightman S. Microvessel count predicts survival in uveal melanoma. Cancer Res 1996; 56: 2900-2903.
12. Damato B. The management of uveal melanoma in the next millennium. Ophthalmol Clin North Am 1999; 12(4): 493-506.
13. Jensen PK, Hansen MK. Ultrasonographic, three-dimensional scanning for determination of intraocular tumor volume. Acta Ophthalmol 1991; 69: 178-186.
14. Romero JM, Finger PT, Rosen RB, Iezzi R. Three-dimensional ultrasound for measurement of choroidal melanomas. Arch Ophthalmol 2001; 119: 1275-1282.
15. Grasbon T, Schriever S, Hoops JP, Mueller AJ. 3D-Ultraschall. Erste Erfahrungen bei verschiedenen Augenerkrankungen. Ophthalmologe 2001; 98: 88-93.
16. Guthoff R. Modellmessungen zur Volumenbestimmung des malignen Aderhautmelanoms. Graefe Arch Klin Ophthalmol 1980; 214: 139-146.
17. Gass JD. Comparison of uveal melanoma growth rates with mitotic index and mortality Arch Ophthalmol 1985; 103: 924-931.
18. Li W, Gragoudas ES, Egan KM. Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma. Arch Ophthalmol 2003; 121: 68-72.
19. Oosterhuis JA, Journee De Korver HG, Kakebeeke Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995; 113: 315-321.
20. Lommatzsch PK, Alberti W, Lommatzsch R, Rohrwacher F. Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques. Graefes Arch Clin Exp Ophthalmol 1994; 232: 482-487.
21. Langmann G, Pendl G, Müllner K, Papaefthymiou G, Guss H. Gamma Knife radiosurgery for uveal melanomas: an 8-year experience. J Neurosurg 2000; 93(suppl 3): 184-188.
22. Kölmel KF, Lippold A, Kulle B, Veltmaat S, Stoltenberg M, Seebacher C. Zur Sterblichkeit am kutanen invasiven malignen Melanom. Hautarzt 2001; 52: 211-218.
23. Sieving P. Fifteen years of work. The COMS outcomes for medium-sized choroidal melanoma. Arch Ophthalmol 2001; 119(7): 1067-1068.
24. Bornfeld N. Diagnose und Therapie maligner Melanome der Uvea (Aderhaut und Ziliarkörper). Ophthalmologe 1992; 89: W61-W78.